208 results on '"Clemente, Diego"'
Search Results
2. Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis
3. Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
4. Exploring digital servitization trajectories within product–service–software space
5. Business Model Innovation and Modularity: Overview of the Literature
6. Graphene oxide films as a novel tool for the modulation of myeloid-derived suppressor cell activity in the context of multiple sclerosis
7. Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses
8. Circular Economy: Overview of Barriers
9. Product-Service Systems (PSS) and Public Policies: Lessons from the Literature
10. Early biochemical analysis of COVID-19 patients helps severity prediction
11. Gastronomia como objeto de prazer?
12. Business Model Innovation and Modularity: Overview of the Literature
13. Evobrutinib therapeutic response is associated with an increase in the number and maturation of peripheral and central classical dendritic cells (P7-3.005)
14. The Adhesion Molecule Anosmin-1 in Neurology: Kallmann Syndrome and Beyond
15. A ROS-based teleoperation framework : Control of a KUKA robot through Virtual Reality
16. Peripheral Myeloid-Derived Suppressor Cells are good biomarkers of the efficacy of Fingolimod in Multiple Sclerosis
17. Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses
18. A ROS-based teleoperation framework : Control of a KUKA robot through Virtual Reality
19. Myeloid-Derived Suppressor Cells are relevant factors to predict the severity of multiple sclerosis
20. Regulatory Cells in Multiple Sclerosis: From Blood to Brain
21. Additional file 1 of Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
22. Additional file 3 of Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
23. Roles of the tissue-type plasminogen activator in immune response
24. The Selective Loss of Purkinje Cells Induces Specific Peripheral Immune Alterations
25. Dynamic roles of FGF-2 and Anosmin-1 in the migration of neuronal precursors from the subventricular zone during pre- and postnatal development
26. TLR4 pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury
27. Early Biochemical Analysis of COVID-19 Patients Helps Severity Prediction
28. Additional file 1 of Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses
29. Additional file 2 of Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses
30. Myeloid-derived suppressor cells support remyelination in a murine model of Multiple Sclerosis by promoting oligodendrocyte precursor cell survival, proliferation and differentiation
31. TLR4-pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury
32. CIRCULATING MYELOID-DERIVED SUPPRESSOR CELLS AS A POTENTIAL BIOINDICATOR OF THE ENDOGENOUS MYELIN REPAIR CAPACITY IN EXPERIMENTAL MULTIPLE SCLEROSIS
33. MYELOID-DERIVED SUPPRESSOR CELL BURDEN IN THE CNS AND BLOOD IS ASSOCIATED WITH DISEASE SEVERITY OF MULTIPLE SCLEROSIS PATIENTS
34. The Adhesion Molecule Anosmin-1 in Neurology: Kallmann Syndrome and Beyond
35. A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis
36. The proportion of Myeloid-Derived Suppressor Cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of Multiple Sclerosis
37. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
38. A commercial probiotic induces tolerogenic and reduces pathogenic responses in experimental autoimmune encephalomyelitis
39. Remielinización en la Esclerosis Múltiple: un cruce de caminos entre el sistema nervioso y el sistema inmune
40. Myeloid‐derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation
41. Megalin Mediates the Influence of Sonic Hedgehog on Oligodendrocyte Precursor Cell Migration and Proliferation During Development
42. Myeloid-Derived Suppressor Cells Limit the Inflammation by Promoting T Lymphocyte Apoptosis in the Spinal Cord of a Murine Model of Multiple Sclerosis
43. The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis
44. Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses
45. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
46. A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis
47. TLR4-pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury
48. A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells
49. A Novel Role for Anosmin-1 in the Adhesion and Migration of Oligodendrocyte Precursors
50. Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.